CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $227,000 | -78.0% | 32,338 | -74.0% | 0.02% | -73.8% |
| Q1 2022 | $1,033,000 | +275.6% | 124,602 | +206.8% | 0.08% | +200.0% |
| Q4 2021 | $275,000 | +27.9% | 40,610 | 0.0% | 0.03% | +16.7% |
| Q3 2021 | $215,000 | -13.0% | 40,610 | -5.6% | 0.02% | -11.1% |
| Q2 2021 | $247,000 | +118.6% | 43,023 | +74.9% | 0.03% | +170.0% |
| Q1 2021 | $113,000 | +37.8% | 24,592 | 0.0% | 0.01% | +66.7% |
| Q4 2020 | $82,000 | +141.2% | 24,592 | +112.9% | 0.01% | +50.0% |
| Q3 2020 | $34,000 | -93.0% | 11,553 | -89.1% | 0.00% | -90.7% |
| Q2 2020 | $488,000 | +388.0% | 105,702 | +305.3% | 0.04% | +138.9% |
| Q1 2020 | $100,000 | – | 26,080 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |